Predictors of long-term clinical endpoints in patients with refractory angina - Wikidata - awgldk - TriplyDB

Predictors of long-term clinical endpoints in patients with refractory angina

Predictors of long-term clinical endpoints in patients with refractory angina

http://www.wikidata.org/entity/Q35135665

about

Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME Era Ethnic Minorities and Coronary Heart Disease: an Update and Future Directions Gaps in Aging Research as it Applies to Rheumatologic Clinical Care.Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.The Effectiveness and Cost-Effectiveness of Spinal Cord Stimulation for Refractory Angina (RASCAL Study): A Pilot Randomized Controlled Trial Safety and efficacy of percutaneous intramyocardial bone marrow cell injection for chronic myocardial ischemia: Long-term results.Current State of Stem Cell Therapy for Ischemic Heart Disease.Epidemiology and pathogenesis of diffuse obstructive coronary artery disease: the role of arterial stiffness, shear stress, monocyte subsets and circulating microparticles.Percutaneous Device to Narrow the Coronary Sinus: Shifting Paradigm in the Treatment of Refractory Angina? A Review of the Literature.The coronary sinus reducer: clinical evidence and technical aspects.Autologous CD34<sup>+</sup> Cell Therapy for Refractory Angina: 2 year Outcomes from the ACT34-CMI Study.A prospective study of patients with refractory angina: outcomes and the role of high-sensitivity troponin T.Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.Cell Therapy for Refractory Angina: A Reappraisal.Refractory angina revisited: stem cells for a growing unmet clinical need?Midterm outcomes of transmyocardial laser revascularization with intramyocardial injection of adipose derived stromal cells for severe refractory angina.New Advances in the Management of Refractory Angina Pectoris Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO)

P2860

Q26745091-D454117F-3C11-474C-AF4D-9C6B3629B0F8 Q26770594-075DB8E8-6B79-4533-B762-C6B62066BDC2 Q30240678-3CF9BA34-754F-41F7-9DBF-5B32723FA7A2 Q30729604-F176DB4A-44A5-4F43-BE1B-0B590EE2C68F Q37320291-BCCE0F4B-B823-4D33-ADB6-E05EA628B760 Q38655874-D28137F2-7A43-4C88-8ACD-9B74749A2952 Q38697092-D579DC25-62D6-4693-86BF-BC5B74BB6D6B Q38860377-E11BB1E7-F60A-4292-A587-D38F9EAAE46A Q39000547-A29F9969-13E4-4F0E-8EA6-6BC2C3CFD747 Q39034193-6A82F906-2B71-4B31-B50F-30058498B2E4 Q39790202-2BFF6E2D-39D2-4FF6-91FE-3FCD95071BFE Q40535232-1F5DFF96-9620-4341-95A0-39DA21FCD438 Q47190217-D105C846-27FB-48E7-B09A-EF43BAB76519 Q48155875-196C5220-49F3-4283-90CE-C93C775F5300 Q50120552-DC1C030F-531A-4112-B1D3-E772CEE9FC60 Q55649548-E8413E32-A140-42B1-B608-AE77F419791B Q57495833-CF29789B-6710-410C-962B-60FD16D436A9 Q58741622-1F6E3EE5-D497-4C39-A2BD-8E69E3511FFE

P2860

Predictors of long-term clinical endpoints in patients with refractory angina

http://www.wikidata.org/entity/Q35135665

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Predictors of long-term clinical endpoints in patients with refractory angina

@ast

Predictors of long-term clinical endpoints in patients with refractory angina

@en

type

label

Predictors of long-term clinical endpoints in patients with refractory angina

@ast

Predictors of long-term clinical endpoints in patients with refractory angina

@en

prefLabel

Predictors of long-term clinical endpoints in patients with refractory angina

@ast

Predictors of long-term clinical endpoints in patients with refractory angina

@en

P1433

Q35135665-56FF7509-F2FA-42F5-8110-CC358236B2D7

P1476

Q35135665-28707891-2E74-46C8-A46E-356888A1D07E

P2093

Q35135665-27FAD83A-53F6-4AF7-B090-C7EF3C56BE7A

Q35135665-674500B9-7505-4821-A764-BFA5F0C7BE74

Q35135665-76C5ACA8-07B6-48C8-A15D-23DB18148F83

Q35135665-7A635D31-E155-4789-9236-C34B4A69FB2D

Q35135665-7F3195FE-DE24-4242-9E9D-CA04A0729BA0

Q35135665-CC579E65-E449-412B-AF40-CEDEC87175C9

P2860

Q35135665-061C5CE5-FE7E-4F03-8675-95261CE311D6

Q35135665-26273E5A-E2B0-43A1-A24A-4FAD1EEE34AD

Q35135665-2B4980C2-60E1-4B4A-9CD1-852F32232B1E

Q35135665-2E717B38-C286-45ED-AE8F-84FB875E7213

Q35135665-3556C45C-AFAD-4C51-AEEA-DA90D97F147B

Q35135665-40588367-1ED0-463F-8125-95F754CC9992

Q35135665-6E9673DB-A197-4561-A21C-6D3AF0B45F8F

Q35135665-74A76AE3-1E54-44D4-B109-4CC818E19CE8

Q35135665-87311B61-2A76-4F1C-B456-E42C91581E55

Q35135665-8888140B-2980-4D30-8EB6-7F15B5C013AD

P31

Q35135665-EF050159-A880-4D9F-84E1-96071D24A46B

P356

Q35135665-E192CC2A-7519-47CF-97B6-C9400DB22245

P433

Q35135665-9BAD24D4-430B-4385-9114-C58CF606E402

P478

Q35135665-43877671-7CBD-4956-B074-983063F513B2

P50

Q35135665-A27E3D13-4BD1-4625-9E8F-89E8087E7906

Q35135665-CA770E4F-ADE7-4B09-9AE1-81F8C09732D9

P577

Q35135665-21020F53-6F61-433B-8002-996789731B58

P698

Q35135665-28A1717D-85AC-42B9-A749-EE22265157F8

P932

Q35135665-35E22E3C-7B01-434D-9C34-5BD3BADD9292

P356

JAHA.114.001287

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Predictors of long-term clinical endpoints in patients with refractory angina

@en

P2093

Eric L Eisenstein

http://www.w3.org/2001/XMLSchema#string

John H Alexander

http://www.w3.org/2001/XMLSchema#string

Linda K Shaw

http://www.w3.org/2001/XMLSchema#string

Peter K Smith

http://www.w3.org/2001/XMLSchema#string

Samuel Broderick

http://www.w3.org/2001/XMLSchema#string

Thomas J Povsic

http://www.w3.org/2001/XMLSchema#string

P2860

Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels.

A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality.

The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina.

Intramyocardial, autologous CD34+ cell therapy for refractory angina.

National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008

Low diagnostic yield of elective coronary angiography.

P31

scholarly article

P356

10.1161/JAHA.114.001287

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Erik Magnus Ohman

Kevin J Anstrom

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25637344

http://www.w3.org/2001/XMLSchema#string

P932

4345862

http://www.w3.org/2001/XMLSchema#string